<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Fischer KR</dc:creator>
  <dc:creator>Testori T</dc:creator>
  <dc:creator>Wachtel H</dc:creator>
  <dc:creator>Mühlemann S</dc:creator>
  <dc:creator>Happe A</dc:creator>
  <dc:creator>Del Fabbro M</dc:creator>
  <dc:date>2019</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">BACKGROUND
The achievement and preservation of an adequate amount of soft tissue around implants is a critical factor for the prognosis of the treatment.


PURPOSE
To evaluate the effectiveness of a porcine dermal matrix applied during second stage implant surgery for horizontal soft tissue augmentation and preservation of dimensional stability.


MATERIALS AND METHODS
Twenty patients (mean age 50.2 ± 11.9 [SD] years) candidate to implant therapy and requiring soft tissue augmentation were recruited in four centers. Augmentation was performed in 24 cases. A porcine dermal matrix was placed into a buccal split-thickness pouch during uncovering surgery. Silicone impressions were taken before surgery (T0), 2 weeks later at suture removal (T2), 6 months (T3), and 24 months (T4) post augmentation. Dimensional changes of soft tissue were evaluated using superimposition of digitalized study casts.


RESULTS
Nineteen patients (23 implants) could be evaluated at 6 months and 13 patients (17 implants) at 24 months. After 6-month follow-up, there was a significant dimensional gain respect to baseline, averaging 0.83 ± 0.64 mm (P &lt; .01). This did not change significantly at 24 months (0.77 ± 0.65 mm, P = .19). The gain was &gt;0.5 mm in 65.2% and 64.7% of the cases, respectively. Soft tissue shrinkage averaged 34.2% ± 77.0% from T2 to T3 (P &lt; .01) and did not change thereafter (P = .39). Shrinkage was more consistent in the posterior mandible than in the maxilla, but not significantly (P = .23 at 6-month and .36 at 24-month). No adverse events occurred.


CONCLUSION
Within the limitations of this prospective case series, the use of a porcine dermal matrix may provide consistent soft tissue augmentation that maintains up to 24-month follow-up, although graft shrinkage may occur in the first 6 months, depending on the location of surgery.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://sonar.ch/global/documents/47559</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1111/cid.12817</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/31309705</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:source>Clinical implant dentistry and related research. - 2019</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">acellular dermal matrix</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">dental implant</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">gingival thickness</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">second stage surgery</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">soft tissue augmentation</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Adult</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Animals</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">Connective Tissue</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">Dental Implants</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Gingiva</dc:subject>
  <dc:subject xmlns:ns11="xml" ns11:lang="en">Humans</dc:subject>
  <dc:subject xmlns:ns12="xml" ns12:lang="en">Maxilla</dc:subject>
  <dc:subject xmlns:ns13="xml" ns13:lang="en">Middle Aged</dc:subject>
  <dc:subject xmlns:ns14="xml" ns14:lang="en">Prospective Studies</dc:subject>
  <dc:subject xmlns:ns15="xml" ns15:lang="en">Swine</dc:subject>
  <dc:title xmlns:ns16="xml" ns16:lang="en">Soft tissue augmentation applying a collagenated porcine dermal matrix during second stage surgery: A prospective multicenter case series.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
